Vaccine News and Research

Latest Vaccine News and Research

Universal childhood vaccination could prevent antimicrobial resistance

A new study from the University of California, Berkeley, published in the journal Nature in April 2020, reports that extending vaccination to all children could help resolve antimicrobial resistance - one of the biggest obstacles to effective healthcare in low-income countries. This is the first study to look at how vaccination is related to the use of antibiotics in low- and middle-income countries.

29 Apr 2020

Australian COVID-19 vaccine candidate shows protective response in pre-clinical trials

Amid the coronavirus pandemic, scientists race to develop a vaccine that can help contain the spread of the virus. The coronavirus disease (COVID-19) has so far infected more than 3.18 million people across the globe. Now, early tests of a potential coronavirus vaccine have shown promise in pre-clinical trials.

29 Apr 2020

Coronaviruses represent a source of pandemic viruses

In a new paper published on the preprint journal bioRxiv in April 2020, researcher T. Konishi argues that the coronavirus family is a constellation of pandemic pathogens, that includes the currently spreading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

29 Apr 2020

GlobalData offers view on Gilead’s suspension of Covid-19 trials in China

Following the news that China trials of Gilead Sciences Inc’s antiviral drug remdesivir in patients with mild symptoms of coronavirus have been suspended due to lack of eligible patients;

From Gilead Sciences, Inc. 29 Apr 2020

International study to evaluate the effects of COVID-19 in pregnancy launched

Researchers at the University of Oxford are today starting a large, international study to evaluate the effects of COVID-19 in pregnancy.

29 Apr 2020

Study reveals SARS-CoV-2 RNA cap structure

A new study published on the preprint server bioRxiv in April 2020 reports the discovery of the structure of the cap created by the novel coronavirus on virally encoded mRNAs. The finding could help create new antiviral strategies.

29 Apr 2020

How toxic are chloroquine and hydroxychloroquine to cells?

The spread of the pandemic disease COVID-19 caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has now reached almost every country of the world, with over 3.11 million cases and over 217,000 deaths as of April 29, 2020.

29 Apr 2020

Epivax and Entos Pharmaceuticals to develop DNA-based vaccine for COVID-19

Entos Pharmaceuticals (Entos), a healthcare biotechnology company that develops next generation nucleic acid medicines using the Fusogenix drug delivery platform, today announced a collaboration with EpiVax, Inc. (EpiVax), a world leading informatics and immunology biotechnology company with a proven track record in vaccine development.

28 Apr 2020

Exploring the use of stem cells for COVID-19 disease

The coronavirus disease (COVID-19) has ravaged across the, infecting more than 3.11 million people in just over four months. As the virus continues to spread, scientists are struggling to find an effective treatment for the infection. Now, a breakthrough discovery on stem cells could help in the battle against COVID-19.

28 Apr 2020

Dominant SARS-CoV-2 strain A2a binds more easily to ACE2 receptors

The COVID-19 pandemic has affected almost all countries across the world, and India is no exception. Researchers have found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone several mutations with time.

28 Apr 2020

New nasopharyngeal swabs move into human trials for COVID-19

Researchers at the Wyss Institute at Harvard University, in collaboration with healthcare, research, and industrial partners, have designed a new, fully injection-molded nasopharyngeal swab that can be manufactured quickly and inexpensively at high volume to help address the nationwide and international shortage of swabs for COVID-19 testing and research.

28 Apr 2020

Caprion - HistoGeneX Expands its biomarker capabilities and deploys molecular COVID-19 testing services

Caprion - HistoGeneX announced today that the company is launching a molecular PCR testing service for identifying patients with COVID-19.

28 Apr 2020

Study could help inform long-term public health response to COVID-19 pandemic

In the most detailed study to date of epidemic spread, an international team of researchers has modeled measles dynamics based on over 40 years of data collected in England and Wales.

28 Apr 2020

Study: Social distancing should be maintained to avoid the resurgence of COVID-19

A new study by epidemiologists at the University of Notre Dame suggests social distancing measures at current levels in many states may need to be maintained until the summer to avoid a potentially deadly resurgence of the coronavirus.

28 Apr 2020

Research on SARS-CoV-2 spike protein may lead to new vaccines and treatments

The virus that causes COVID-19 is studded on its exterior with "spike proteins," a key component in its ability to infect human cells. Two University of Georgia researchers, Rob Woods and Parastoo Azadi, are investigating the proteins and sugars on the surface of the virus with the goal of finding information that could lead to vaccines and therapeutics.

28 Apr 2020

Researchers develop a new, promising treatment for HIV

A novel means to prevent HIV infection was developed at the University of Nebraska Medical Center that could allow people with or at risk of acquiring the virus to take medicines once a year.

28 Apr 2020

India's Serum Institute gears up to make millions of doses of potential COVID-19 vaccine

The Serum Institute of India plans to start manufacturing Oxford University's COVID-19 vaccine in 3 weeks to get a head start on production, the company announced. This comes even as experts warn that any successful vaccine will take two or more years to come on the market.

28 Apr 2020

COVID-19 can trigger serious inflammatory-related cardiovascular problems

The coronavirus disease (COVID-19) is potentially fatal for vulnerable populations like seniors who over 60 years old, and those with underlying medical conditions, like heart disease, diabetes, and lung disease. Reports show that patients are suffering from heart impairment caused by COVID-19. A new study sheds light on the effect of the novel coronavirus on the heart, causing cardiovascular problems, even in those without underlying heart conditions.

27 Apr 2020

Using neutralising antibodies in the fight against COVID-19

While many scientists and pharmaceutical companies are racing to develop a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, there is also an urgent need for a coronavirus disease (COVID-19) treatment. The potent virus has now spread to 210 countries and territories, affecting more than 3.04 million people. Now, a team of German scientists is working on using antibodies to prevent and treat COVID-19.

27 Apr 2020

Researchers develop new ICU ventilator prototype to fight against COVID-19

Researchers and technicians from the Universidad Carlos III de Madrid and the University Hospital Gregorio Marañón have designed and developed a new ventilator prototype for Intensive Care Units in the fight against the health crisis caused by COVID-19.

27 Apr 2020